Jazz Pharmaceuticals launches USD 1 billion exchangeable senior notes offering due 2032 - JAZZ News | RalliesJazz Pharmaceuticals launches USD 1 billion exchangeable senior notes offering due 2032
J
JAZZ• Planned share repurchase
- Jazz Pharmaceuticals also plans a concurrent repurchase of up to USD 225 million of ordinary shares from note buyers, funded with existing cash.
Exchangeable senior notes offering
- Jazz Pharmaceuticals launched a private offering of USD 1 billion exchangeable senior notes due 2032.
- The deal includes a 13-day option for initial purchasers to buy up to an additional USD 150 million of notes.
- Net proceeds are earmarked for general corporate purposes.
LASR
•
